These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7221948)
1. [Gentamycin resistance of gram negative bacteria in clinical materials]. Baier R; Puppel H Ther Ggw; 1981 Feb; 120(2):127-36. PubMed ID: 7221948 [No Abstract] [Full Text] [Related]
2. [Use of gentamicin in severe gram-negative infections]. Klastersky J; Cappel R Schweiz Rundsch Med Prax; 1973 Apr; 62(17):537-42. PubMed ID: 4574009 [No Abstract] [Full Text] [Related]
3. [Effectiveness of gentamycin sulfate in the treatment of the infectious complications of oncological patients]. Dronova OM; Smolianskaia AZ Antibiotiki; 1978 Oct; 23(10):940-6. PubMed ID: 360982 [No Abstract] [Full Text] [Related]
4. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects]. Romoli E; Di Leonardo F; Giordano G; De Felice M; Cerquetti F; Vonmoos A Minerva Urol; 1981; 33(2):85-90. PubMed ID: 7322100 [No Abstract] [Full Text] [Related]
5. [Experience in using an antibiotic from the aminoglycoside group, gentamicin (garamycin), in the surgical clinic]. Govorovich EA; Marshak AM; Iakovlev VP; Lunacharskaia TV Klin Med (Mosk); 1972 Nov; 50(11):102-5. PubMed ID: 4666689 [No Abstract] [Full Text] [Related]
6. Antibiotic resistance: how it arises, the current position and strategies for the future. Perry C; Hall C Nurs Times; 2009 Sep 15-21; 105(36):20-3. PubMed ID: 19835196 [TBL] [Abstract][Full Text] [Related]
8. [Report on the Gentamycin-Symposium in Düsseldorf]. Reuter H ZFA (Stuttgart); 1976 Sep; 52(25):1295-9. PubMed ID: 983245 [No Abstract] [Full Text] [Related]
9. [Treatment of the exacerbation of chronic suppurative bronchitis with gentamycin]. Mishustina EL; Shteĭngardt IuN Sov Med; 1988; (8):61-4. PubMed ID: 3201329 [No Abstract] [Full Text] [Related]
10. Isolated bacteria and susceptibilities to antimicrobial agents in biliary infections. Mukaiya M; Hirata K; Katsuramaki T; Kihara C; Kimura Y; Yamaguchi K; Furuhata T; Hata F Hepatogastroenterology; 2005; 52(63):686-90. PubMed ID: 15966183 [TBL] [Abstract][Full Text] [Related]
11. Current status and changing trends of antimicrobial resistance in Lebanon. Araj GF; Kanj SS J Med Liban; 2000; 48(4):221-6. PubMed ID: 11214193 [TBL] [Abstract][Full Text] [Related]
12. [Data on the effectiveness of a new aminoglycoside antibiotic in the treatment of urinary tract infections]. Trischitta C; Urso G; Caruso L; Calcara G Minerva Urol; 1980; 32(1):49-58. PubMed ID: 7382968 [No Abstract] [Full Text] [Related]
13. [Results of a 6-year long use of gentamicin in medical resuscitation (1966-1972)]. Vachon F; Witchitz J; Bousser P; Dupont V Schweiz Rundsch Med Prax; 1973 Apr; 62(17):543-7. PubMed ID: 4574010 [No Abstract] [Full Text] [Related]
14. Aerobic bacteria isolated from blood cultures of patients and their antibiotic susceptibilities in Harare, Zimbabwe. Obi CL; Mazarura E Cent Afr J Med; 1996 Dec; 42(12):332-6. PubMed ID: 9164012 [TBL] [Abstract][Full Text] [Related]
15. Netilmicin sulfate (Netromycin). Med Lett Drugs Ther; 1983 Jul; 25(639):65-7. PubMed ID: 6865848 [No Abstract] [Full Text] [Related]
16. [Spectrum and sensitivity of bacterial microorganisms in the treatment of bone infections with gentamycin-polymethylmethacrylate]. Dingeldein E Aktuelle Probl Chir Orthop; 1979; (12):113-20. PubMed ID: 36770 [No Abstract] [Full Text] [Related]
17. [Clinico-pharmacological studies with Gentamycin as a broad-spectrum antibiotic II. Clinical studies with Gentamycin]. Bíró L; Iván E; Arr M; Perényi T Orv Hetil; 1969 May; 110(21):1185-8. PubMed ID: 4893523 [No Abstract] [Full Text] [Related]